Global Respiratory Diagnostics

Respiratory Diagnostics Comprehensive Study by Type (Mechanical Tests, OSA Diagnostic Tests, Imaging Tests, Others), Application (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Others), Component (Instruments and Devices, Assays and Reagents, Services and Software), Tests (Arterial Blood Gases, Oximetry, Chest X- ray, Computerized Tomographic scan (CT scan), Sleep Study (Polysomnography), Spirometry, Others) Players and Region - Global Market Outlook to 2030

Respiratory Diagnostics Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Respiratory Diagnostics
Respiratory problems are associated to lungs its diagnostics are broadly classified as invasive procedures and non-invasive procedures. Chronic Respiratory Diseases (CRDs) and Severe Acute Respiratory Syndrome (SARS) are related to air passage in the lungs, some of the most common CRDs include Occupational Lung diseases, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and the Pulmonary Hypertension. Increasing risk factors, air pollution, addiction smoking, and the Covid-19 etc. have led to kink in the respiratory diagnostics market. However, CRDs cannot be cured hence diagnostic tests are performed at the Initial stages of the disease or for early identification given the symptoms.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Respiratory Diagnostics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

3M (United States), Philips Healthcare (Netherlands), Becton, Dickinson and Company (United States), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Alere Inc. (United States), BioMerieux (France), Bio-Rad Laboratories, Inc. (United States), COSMED srl (Italy) and Philips (Netherlands) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are SDI Diagnostics Inc. (United States), Roche Holding AG (Switzerland) and AireHealth Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Respiratory Diagnostics market by Type (Mechanical Tests, OSA Diagnostic Tests, Imaging Tests and Others), Application (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices and Others) and Region.



On the basis of geography, the market of Respiratory Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Component, the sub-segment i.e. Instruments and Devices will boost the Respiratory Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Tests, the sub-segment i.e. Arterial Blood Gases will boost the Respiratory Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technical Progress in Medical Industry and Heavy Investments in Research & Development

Market Growth Drivers:
Prevalence of Severe Acute Respiratory Syndrome (SARS) Cases and Climate Change Leading to Reparatory Disabilities

Challenges:
Emergence of Advance and Effective Techniques

Restraints:
Highly Priced Surgical Procedures

Opportunities:
Growth in Healthcare infrastructure Due to Pandemic and Improved Nucleic Acid Amplification Tests Have Enhanced Virus Identification

Market Leaders and their expansionary development strategies

In March, 2021 - XPhyto Announced Approval form European Union for its “25 Minute COVID-19 PCR Test”
European Union, CAMD Medical Devices Regulation/In-vitro Diagnostics Regulation (MDR/IVDR) – CAMD is one of the Official Regulatory Authority, the Guidelines are Based on Concerns Relating to Manufacture and Sale of Diagnostic Medical Devices across the European Union and United States FDA Class II Special Controls Guideline - The Regulation Provides Criterions and Guidelines for Identification and classification of Diagnostic procedures, any new Device should be Approved by FDA

Key Target Audience
Respiratory Diagnostics Devices Manufactures, Respiratory Diagnostics Devices Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Mechanical Tests
  • OSA Diagnostic Tests
  • Imaging Tests
  • Others
By Application
  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Others
By Component
  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

By Tests
  • Arterial Blood Gases
  • Oximetry
  • Chest X- ray
  • Computerized Tomographic scan (CT scan)
  • Sleep Study (Polysomnography)
  • Spirometry
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Severe Acute Respiratory Syndrome (SARS) Cases
      • 3.2.2. Climate Change Leading to Reparatory Disabilities
    • 3.3. Market Challenges
      • 3.3.1. Emergence of Advance and Effective Techniques
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Medical Industry
      • 3.4.2. Heavy Investments in Research & Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Respiratory Diagnostics, by Type, Application, Component, Tests and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Respiratory Diagnostics (Value)
      • 5.2.1. Global Respiratory Diagnostics by: Type (Value)
        • 5.2.1.1. Mechanical Tests
        • 5.2.1.2. OSA Diagnostic Tests
        • 5.2.1.3. Imaging Tests
        • 5.2.1.4. Others
      • 5.2.2. Global Respiratory Diagnostics by: Application (Value)
        • 5.2.2.1. Hospital/Clinical Laboratories
        • 5.2.2.2. Reference Laboratories
        • 5.2.2.3. Physician Offices
        • 5.2.2.4. Others
      • 5.2.3. Global Respiratory Diagnostics by: Component (Value)
        • 5.2.3.1. Instruments and Devices
        • 5.2.3.2. Assays and Reagents
        • 5.2.3.3. Services and Software
      • 5.2.4. Global Respiratory Diagnostics by: Tests (Value)
        • 5.2.4.1. Arterial Blood Gases
        • 5.2.4.2. Oximetry
        • 5.2.4.3. Chest X- ray
        • 5.2.4.4. Computerized Tomographic scan (CT scan)
        • 5.2.4.5. Sleep Study (Polysomnography)
        • 5.2.4.6. Spirometry
        • 5.2.4.7. Others
      • 5.2.5. Global Respiratory Diagnostics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Respiratory Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Philips Healthcare (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton, Dickinson and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alere Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMerieux (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. COSMED srl (Italy)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Philips (Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Respiratory Diagnostics Sale, by Type, Application, Component, Tests and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Respiratory Diagnostics (Value)
      • 7.2.1. Global Respiratory Diagnostics by: Type (Value)
        • 7.2.1.1. Mechanical Tests
        • 7.2.1.2. OSA Diagnostic Tests
        • 7.2.1.3. Imaging Tests
        • 7.2.1.4. Others
      • 7.2.2. Global Respiratory Diagnostics by: Application (Value)
        • 7.2.2.1. Hospital/Clinical Laboratories
        • 7.2.2.2. Reference Laboratories
        • 7.2.2.3. Physician Offices
        • 7.2.2.4. Others
      • 7.2.3. Global Respiratory Diagnostics by: Component (Value)
        • 7.2.3.1. Instruments and Devices
        • 7.2.3.2. Assays and Reagents
        • 7.2.3.3. Services and Software
      • 7.2.4. Global Respiratory Diagnostics by: Tests (Value)
        • 7.2.4.1. Arterial Blood Gases
        • 7.2.4.2. Oximetry
        • 7.2.4.3. Chest X- ray
        • 7.2.4.4. Computerized Tomographic scan (CT scan)
        • 7.2.4.5. Sleep Study (Polysomnography)
        • 7.2.4.6. Spirometry
        • 7.2.4.7. Others
      • 7.2.5. Global Respiratory Diagnostics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Respiratory Diagnostics: by Type(USD Million)
  • Table 2. Respiratory Diagnostics Mechanical Tests , by Region USD Million (2018-2023)
  • Table 3. Respiratory Diagnostics OSA Diagnostic Tests , by Region USD Million (2018-2023)
  • Table 4. Respiratory Diagnostics Imaging Tests , by Region USD Million (2018-2023)
  • Table 5. Respiratory Diagnostics Others , by Region USD Million (2018-2023)
  • Table 6. Respiratory Diagnostics: by Application(USD Million)
  • Table 7. Respiratory Diagnostics Hospital/Clinical Laboratories , by Region USD Million (2018-2023)
  • Table 8. Respiratory Diagnostics Reference Laboratories , by Region USD Million (2018-2023)
  • Table 9. Respiratory Diagnostics Physician Offices , by Region USD Million (2018-2023)
  • Table 10. Respiratory Diagnostics Others , by Region USD Million (2018-2023)
  • Table 11. Respiratory Diagnostics: by Component(USD Million)
  • Table 12. Respiratory Diagnostics Instruments and Devices , by Region USD Million (2018-2023)
  • Table 13. Respiratory Diagnostics Assays and Reagents , by Region USD Million (2018-2023)
  • Table 14. Respiratory Diagnostics Services and Software , by Region USD Million (2018-2023)
  • Table 15. Respiratory Diagnostics: by Tests(USD Million)
  • Table 16. Respiratory Diagnostics Arterial Blood Gases , by Region USD Million (2018-2023)
  • Table 17. Respiratory Diagnostics Oximetry , by Region USD Million (2018-2023)
  • Table 18. Respiratory Diagnostics Chest X- ray , by Region USD Million (2018-2023)
  • Table 19. Respiratory Diagnostics Computerized Tomographic scan (CT scan) , by Region USD Million (2018-2023)
  • Table 20. Respiratory Diagnostics Sleep Study (Polysomnography) , by Region USD Million (2018-2023)
  • Table 21. Respiratory Diagnostics Spirometry , by Region USD Million (2018-2023)
  • Table 22. Respiratory Diagnostics Others , by Region USD Million (2018-2023)
  • Table 23. South America Respiratory Diagnostics, by Country USD Million (2018-2023)
  • Table 24. South America Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 25. South America Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 26. South America Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 27. South America Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 28. Brazil Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 29. Brazil Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 30. Brazil Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 31. Brazil Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 32. Argentina Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 33. Argentina Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 34. Argentina Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 35. Argentina Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 36. Rest of South America Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 37. Rest of South America Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 38. Rest of South America Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 39. Rest of South America Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 40. Asia Pacific Respiratory Diagnostics, by Country USD Million (2018-2023)
  • Table 41. Asia Pacific Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 42. Asia Pacific Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 43. Asia Pacific Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 44. Asia Pacific Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 45. China Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 46. China Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 47. China Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 48. China Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 49. Japan Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 50. Japan Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 51. Japan Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 52. Japan Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 53. India Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 54. India Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 55. India Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 56. India Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 57. South Korea Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 58. South Korea Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 59. South Korea Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 60. South Korea Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 61. Taiwan Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 62. Taiwan Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 63. Taiwan Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 64. Taiwan Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 65. Australia Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 66. Australia Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 67. Australia Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 68. Australia Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 73. Europe Respiratory Diagnostics, by Country USD Million (2018-2023)
  • Table 74. Europe Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 75. Europe Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 76. Europe Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 77. Europe Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 78. Germany Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 79. Germany Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 80. Germany Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 81. Germany Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 82. France Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 83. France Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 84. France Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 85. France Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 86. Italy Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 87. Italy Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 88. Italy Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 89. Italy Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 90. United Kingdom Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 91. United Kingdom Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 92. United Kingdom Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 93. United Kingdom Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 94. Netherlands Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 95. Netherlands Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 96. Netherlands Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 97. Netherlands Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 98. Rest of Europe Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 99. Rest of Europe Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 100. Rest of Europe Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 101. Rest of Europe Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 102. MEA Respiratory Diagnostics, by Country USD Million (2018-2023)
  • Table 103. MEA Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 104. MEA Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 105. MEA Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 106. MEA Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 107. Middle East Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 108. Middle East Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 109. Middle East Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 110. Middle East Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 111. Africa Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 112. Africa Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 113. Africa Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 114. Africa Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 115. North America Respiratory Diagnostics, by Country USD Million (2018-2023)
  • Table 116. North America Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 117. North America Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 118. North America Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 119. North America Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 120. United States Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 121. United States Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 122. United States Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 123. United States Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 124. Canada Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 125. Canada Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 126. Canada Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 127. Canada Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 128. Mexico Respiratory Diagnostics, by Type USD Million (2018-2023)
  • Table 129. Mexico Respiratory Diagnostics, by Application USD Million (2018-2023)
  • Table 130. Mexico Respiratory Diagnostics, by Component USD Million (2018-2023)
  • Table 131. Mexico Respiratory Diagnostics, by Tests USD Million (2018-2023)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Respiratory Diagnostics: by Type(USD Million)
  • Table 143. Respiratory Diagnostics Mechanical Tests , by Region USD Million (2025-2030)
  • Table 144. Respiratory Diagnostics OSA Diagnostic Tests , by Region USD Million (2025-2030)
  • Table 145. Respiratory Diagnostics Imaging Tests , by Region USD Million (2025-2030)
  • Table 146. Respiratory Diagnostics Others , by Region USD Million (2025-2030)
  • Table 147. Respiratory Diagnostics: by Application(USD Million)
  • Table 148. Respiratory Diagnostics Hospital/Clinical Laboratories , by Region USD Million (2025-2030)
  • Table 149. Respiratory Diagnostics Reference Laboratories , by Region USD Million (2025-2030)
  • Table 150. Respiratory Diagnostics Physician Offices , by Region USD Million (2025-2030)
  • Table 151. Respiratory Diagnostics Others , by Region USD Million (2025-2030)
  • Table 152. Respiratory Diagnostics: by Component(USD Million)
  • Table 153. Respiratory Diagnostics Instruments and Devices , by Region USD Million (2025-2030)
  • Table 154. Respiratory Diagnostics Assays and Reagents , by Region USD Million (2025-2030)
  • Table 155. Respiratory Diagnostics Services and Software , by Region USD Million (2025-2030)
  • Table 156. Respiratory Diagnostics: by Tests(USD Million)
  • Table 157. Respiratory Diagnostics Arterial Blood Gases , by Region USD Million (2025-2030)
  • Table 158. Respiratory Diagnostics Oximetry , by Region USD Million (2025-2030)
  • Table 159. Respiratory Diagnostics Chest X- ray , by Region USD Million (2025-2030)
  • Table 160. Respiratory Diagnostics Computerized Tomographic scan (CT scan) , by Region USD Million (2025-2030)
  • Table 161. Respiratory Diagnostics Sleep Study (Polysomnography) , by Region USD Million (2025-2030)
  • Table 162. Respiratory Diagnostics Spirometry , by Region USD Million (2025-2030)
  • Table 163. Respiratory Diagnostics Others , by Region USD Million (2025-2030)
  • Table 164. South America Respiratory Diagnostics, by Country USD Million (2025-2030)
  • Table 165. South America Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 166. South America Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 167. South America Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 168. South America Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 169. Brazil Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 170. Brazil Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 171. Brazil Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 172. Brazil Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 173. Argentina Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 174. Argentina Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 175. Argentina Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 176. Argentina Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 177. Rest of South America Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 178. Rest of South America Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 179. Rest of South America Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 180. Rest of South America Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 181. Asia Pacific Respiratory Diagnostics, by Country USD Million (2025-2030)
  • Table 182. Asia Pacific Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 183. Asia Pacific Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 184. Asia Pacific Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 185. Asia Pacific Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 186. China Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 187. China Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 188. China Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 189. China Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 190. Japan Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 191. Japan Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 192. Japan Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 193. Japan Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 194. India Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 195. India Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 196. India Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 197. India Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 198. South Korea Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 199. South Korea Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 200. South Korea Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 201. South Korea Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 202. Taiwan Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 203. Taiwan Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 204. Taiwan Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 205. Taiwan Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 206. Australia Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 207. Australia Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 208. Australia Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 209. Australia Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 211. Rest of Asia-Pacific Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 212. Rest of Asia-Pacific Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 213. Rest of Asia-Pacific Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 214. Europe Respiratory Diagnostics, by Country USD Million (2025-2030)
  • Table 215. Europe Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 216. Europe Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 217. Europe Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 218. Europe Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 219. Germany Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 220. Germany Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 221. Germany Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 222. Germany Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 223. France Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 224. France Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 225. France Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 226. France Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 227. Italy Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 228. Italy Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 229. Italy Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 230. Italy Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 231. United Kingdom Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 232. United Kingdom Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 233. United Kingdom Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 234. United Kingdom Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 235. Netherlands Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 236. Netherlands Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 237. Netherlands Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 238. Netherlands Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 239. Rest of Europe Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 240. Rest of Europe Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 241. Rest of Europe Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 242. Rest of Europe Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 243. MEA Respiratory Diagnostics, by Country USD Million (2025-2030)
  • Table 244. MEA Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 245. MEA Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 246. MEA Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 247. MEA Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 248. Middle East Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 249. Middle East Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 250. Middle East Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 251. Middle East Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 252. Africa Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 253. Africa Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 254. Africa Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 255. Africa Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 256. North America Respiratory Diagnostics, by Country USD Million (2025-2030)
  • Table 257. North America Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 258. North America Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 259. North America Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 260. North America Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 261. United States Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 262. United States Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 263. United States Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 264. United States Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 265. Canada Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 266. Canada Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 267. Canada Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 268. Canada Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 269. Mexico Respiratory Diagnostics, by Type USD Million (2025-2030)
  • Table 270. Mexico Respiratory Diagnostics, by Application USD Million (2025-2030)
  • Table 271. Mexico Respiratory Diagnostics, by Component USD Million (2025-2030)
  • Table 272. Mexico Respiratory Diagnostics, by Tests USD Million (2025-2030)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Respiratory Diagnostics: by Type USD Million (2018-2023)
  • Figure 5. Global Respiratory Diagnostics: by Application USD Million (2018-2023)
  • Figure 6. Global Respiratory Diagnostics: by Component USD Million (2018-2023)
  • Figure 7. Global Respiratory Diagnostics: by Tests USD Million (2018-2023)
  • Figure 8. South America Respiratory Diagnostics Share (%), by Country
  • Figure 9. Asia Pacific Respiratory Diagnostics Share (%), by Country
  • Figure 10. Europe Respiratory Diagnostics Share (%), by Country
  • Figure 11. MEA Respiratory Diagnostics Share (%), by Country
  • Figure 12. North America Respiratory Diagnostics Share (%), by Country
  • Figure 13. Global Respiratory Diagnostics share by Players 2023 (%)
  • Figure 14. Global Respiratory Diagnostics share by Players (Top 3) 2023(%)
  • Figure 15. Global Respiratory Diagnostics share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 18. 3M (United States) Revenue: by Geography 2023
  • Figure 19. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 20. Philips Healthcare (Netherlands) Revenue: by Geography 2023
  • Figure 21. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 22. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 25. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Alere Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Alere Inc. (United States) Revenue: by Geography 2023
  • Figure 29. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 30. BioMerieux (France) Revenue: by Geography 2023
  • Figure 31. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. COSMED srl (Italy) Revenue, Net Income and Gross profit
  • Figure 34. COSMED srl (Italy) Revenue: by Geography 2023
  • Figure 35. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 36. Philips (Netherlands) Revenue: by Geography 2023
  • Figure 37. Global Respiratory Diagnostics: by Type USD Million (2025-2030)
  • Figure 38. Global Respiratory Diagnostics: by Application USD Million (2025-2030)
  • Figure 39. Global Respiratory Diagnostics: by Component USD Million (2025-2030)
  • Figure 40. Global Respiratory Diagnostics: by Tests USD Million (2025-2030)
  • Figure 41. South America Respiratory Diagnostics Share (%), by Country
  • Figure 42. Asia Pacific Respiratory Diagnostics Share (%), by Country
  • Figure 43. Europe Respiratory Diagnostics Share (%), by Country
  • Figure 44. MEA Respiratory Diagnostics Share (%), by Country
  • Figure 45. North America Respiratory Diagnostics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • 3M (United States)
  • Philips Healthcare (Netherlands)
  • Becton, Dickinson and Company (United States)
  • Abbott Laboratories (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Alere Inc. (United States)
  • BioMerieux (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • COSMED srl (Italy)
  • Philips (Netherlands)
Additional players considered in the study are as follows:
SDI Diagnostics Inc. (United States) , Roche Holding AG (Switzerland) , AireHealth Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 241 Pages 85 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Respiratory Diagnostics Quantitative research analysis
Global Respiratory Diagnostics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as 3M (United States), Philips Healthcare (Netherlands), Becton, Dickinson and Company (United States), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Alere Inc. (United States), BioMerieux (France), Bio-Rad Laboratories, Inc. (United States), COSMED srl (Italy) and Philips (Netherlands) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technical Progress in Medical Industry " is seen as one of major influencing trends for Respiratory Diagnostics Market during projected period 2023-2030.
The Respiratory Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Respiratory Diagnostics Report?

Have a Query? Click Here

Other Related Reports

Vocal Biomarkers Comprehensive Study by Type (Amplitude, Error rate, Frequency, Vocal rise or fall time, Voice tremor, Pitch, Others), Indication (Psychiatric Disorders, Neurological Disorders, Respi...
$ 3750
High-Throughput Screening Comprehensive Study by Type (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, Services), Application (Chemical Biology Programs, Cell- & Organ-Based ...
$ 3750
Hemorrhagic Shock Treatment Comprehensive Study by Causes (Severe Burns, Deep Cuts, Gunshot Wounds, Others), Diagnosis (X-rays, Blood tests, Ultrasound, CT scan, MRI), Symptoms (Abdominal Pain, Abdom...
$ 3500
NewBorn Screening Comprehensive Study by Type (Instruments {Newborn Disorder Screening Instruments, Newborn Hearing Screening Instruments (Hearing Screening Devices and Hearing Screening Accessories)...
$ 3750
Interventional Radiology Comprehensive Study by Type (X-ray, Computed Tomography, Magnetic Resonance Imaging (MRI), Ultrasound), Application (Oncology, Cardiology, Urology & Nephrology, Gastroenterol...
$ 3750
Wireless Health and Fitness Devices Comprehensive Study by Type (Wrist Strap Type Devices, Wearable Type Devices, Other), Application (Monitoring, Diagnosis), Sales Channel (Pharmacies, Online Channe...
$ 3750